Overview

Bioequivalence of Two Formulations of Acyclovir

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Bioequivalence of two formulations of Acyclovir (Acyclovir Lyophilized I.V. infusion 250mg) after Intravenous Infusion in Healthy Volunteers.
Phase:
Phase 4
Details
Lead Sponsor:
Yung Shin Pharm. Ind. Co., Ltd.
Treatments:
Acyclovir